Clarke Christine M, Plata Cara, Cole Bonnie, Tsuchiya Karen, La Spada Albert R, Kapur Raj P
Department of Laboratories, Children's Hospital and Regional Medical Center, Seattle, Washington, USA.
Gastroenterology. 2007 Dec;133(6):1971-8. doi: 10.1053/j.gastro.2007.08.043. Epub 2007 Aug 21.
BACKGROUND & AIMS: Intestinal dysmotility is a component of many neurodegenerative disorders, including some characterized by neuronal intranuclear inclusions. PrP-SCA7-92Q transgenic mice phenocopy many aspects of the human polyglutamine neurodegenerative disorder spinocerebellar ataxia type 7 (SCA7). The enteric neuropathology of PrP-SCA7-92Q mice was investigated after observing that they develop signs of intestinal pseudo-obstruction.
Gastrointestinal transit of radio-opaque pellets through presymptomatic and symptomatic PrP-SCA7-92Q mice and nontransgenic littermates was compared. Gross, microscopic, and ultrastructural studies were conducted, along with histologic and whole mount immunohistochemistry, to identify intranuclear inclusions and quantify subsets of enteric neurons. Immunoblot analysis was performed to confirm selective loss of particular neuronal populations.
A subset of cholinergic enteric ganglion cells in PrP-SCA7-92Q mice harbor nuclear inclusions composed of transgene-derived ataxin-7, which contains a pathogenic polyglutamine expansion. These animals die between 15 and 20 weeks of age with intestinal distension and enterocolitis. Signs of disease are preceded by selective loss of nitric oxide synthase-positive neurons (which lack nuclear inclusions), loss of nerve fibers in the myenteric nerve plexus, and delayed gastrointestinal transit. Cholinergic neurons, including those with inclusions, are spared.
PrP-SCA7-92Q mice may be useful models for human intestinal pseudoobstruction, particularly visceral neuropathies with neuronal intranuclear inclusions. Loss of inclusion-free inhibitory neurons supports the hypothesis that inclusions may be neuroprotective or coincidental, as opposed to harbingers of neuron death. Because enteric neuropathology in PrP-SCA7-92Q animals is easily missed by routine histopathology, quantitative immunohistochemical approaches may be required to recognize analogous forms of human enteric neuropathy.
肠道运动障碍是许多神经退行性疾病的一个组成部分,包括一些以神经元核内包涵体为特征的疾病。PrP-SCA7-92Q转基因小鼠模拟了人类多聚谷氨酰胺神经退行性疾病脊髓小脑共济失调7型(SCA7)的许多方面。在观察到PrP-SCA7-92Q小鼠出现肠道假性梗阻迹象后,对其肠道神经病理学进行了研究。
比较不透X线的药丸在症状前和有症状的PrP-SCA7-92Q小鼠及非转基因同窝小鼠中的胃肠道转运情况。进行大体、显微镜和超微结构研究,以及组织学和整装免疫组织化学,以识别核内包涵体并对肠神经元亚群进行定量。进行免疫印迹分析以确认特定神经元群体的选择性丧失。
PrP-SCA7-92Q小鼠的一部分胆碱能肠神经节细胞含有由转基因衍生的ataxin-7组成的核内包涵体,ataxin-7含有致病性多聚谷氨酰胺扩增。这些动物在15至20周龄时死于肠道扩张和小肠结肠炎。在疾病症状出现之前,一氧化氮合酶阳性神经元(缺乏核内包涵体)选择性丧失、肌间神经丛神经纤维丧失以及胃肠道转运延迟。胆碱能神经元,包括那些有包涵体的神经元,未受影响。
PrP-SCA7-92Q小鼠可能是人类肠道假性梗阻,特别是伴有神经元核内包涵体的内脏神经病变的有用模型。无包涵体抑制性神经元的丧失支持了这样的假设,即包涵体可能具有神经保护作用或只是巧合,而不是神经元死亡的先兆。由于常规组织病理学很容易遗漏PrP-SCA7-92Q动物的肠道神经病理学,可能需要定量免疫组织化学方法来识别类似形式的人类肠道神经病变。